SDZNY OTC
Sandoz Group AG
1W: +6.2%
1M: +14.7%
3M: +20.9%
YTD: +36.1%
1Y: +59.1%
3Y: +237.7%
$99.36
-0.32 (-0.32%)
Pre-Market: $99.12 (-0.24, -0.24%)
Weekly Expected Move ±3.5%
$90
$94
$97
$101
$104
Credit Risk of going bust: lower than 76% of companies Debt: 12.7% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $1.15 (down 99%), Sandoz Group AG would be worth roughly what it owes.
Total debt $6.20B against a stock market value of $42.81B.
Distance to default 8.75 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $3.68B (short-term plus half of long-term), stock volatility 31.3%; Altman Z'' 2.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $6.20B against a stock market value of $42.81B.
Distance to default 8.75 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $3.68B (short-term plus half of long-term), stock volatility 31.3%; Altman Z'' 2.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$42.8B
52W Range62.26-100.34
Volume3,690
Avg Volume23,349
Beta0.49
Dividend$1.02
Analyst Ratings
Company Info
CEORichard Saynor
Employees23,000
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2023-10-04
Websitesandoz.com
Centralbahnstrasse 4
Basel, ZG 4051
CH
Basel, ZG 4051
CH
41 61 324 11 11
About Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.
Latest News
NBIX vs. SDZNY: Which Stock Should Value Investors Buy Now?
GRFS vs. SDZNY: Which Stock Should Value Investors Buy Now?
Sandoz wins Canada nod for generic Ozempic; inks licensing deal for generic Hemlibra
Looming biosimilar void risks $189B in lost U.S. healthcare savings: report
GRFS or SDZNY: Which Is the Better Value Stock Right Now?
Recent Insider Trades
No insider trades found